Page last updated: 2024-10-27

gabexate and Becker Muscular Dystrophy

gabexate has been researched along with Becker Muscular Dystrophy in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"Duchenne muscular dystrophy is known to be caused by a defective gene of dystrophin, a 427-kDa cytoskeletal protein, but the effective therapeutic drug is presently unavailable."1.32Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice. ( Ban, S; Kakefuda, R; Kikukawa, Y; Nagahiro, K; Sawada, H; Shiomi, T; Yokosawa, H, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawada, H1
Nagahiro, K1
Kikukawa, Y1
Ban, S1
Kakefuda, R1
Shiomi, T1
Yokosawa, H1

Other Studies

1 other study available for gabexate and Becker Muscular Dystrophy

ArticleYear
Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:7

    Topics: Animals; Esters; Gabexate; Guanidines; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal;

2003